News

The UN Convention on Biological Diversity (UN CBD) and its sub-protocols are the world's most important forums for establishing internationally binding regulations for Gene Drive technology. For the first time since the beginning of the COVID pandemic - after more than two years of repeated postponements and online meetings - government officials, civil society, scientists and business lobbyists met in person to resume international negotiations in Geneva (Switzerland) between 14-29 March 2022.

On Oct. 6, 2021, the European Parliament called on the EU Commission and EU member states, through its report on "The role of development policy in combating biodiversity loss not to promote genetic technologies with development aid funds and, in particular, not to allow the release of Gene Drive organisms.

Gene drive technology carries high risks. Yet it is being promoted by the Bill & Melinda Gates Foundation as a solution to malaria. On the occasion of World Malaria Day, the Stop Gene Drives campaign is launching a project that presents different perspectives on the issue of malaria control and highlights alternative, possibly less risky approaches and innovations to combat malaria.

An alliance of European NGOs commissioned a representative opinion poll to determine how the European population evaluates gene drive technologyand how well known the issue is.The response of a majority of citizens in eight European countries is: “No, the risks are too high”. This first opinion poll on the subject shows high levels of opposition to and very low levels of support for the use of gene drive technology in the environment.

In an open letter initiated by Greenpeace EU, Friends of the Earth Europe, IFOAM EU and the German initiative Save Our Seeds, 78 environmental, agricultural, animal welfare and development aid organizsations from all over Europe are calling on the EU Commission to outlaw the release of so-called Gene Drive Organisms in the EU and internationally.